openPR Logo
Press release

Erectile Dysfunction Market Size to Reach Revenues of over $4 Billion by 2023 – Arizton

The global erectile dysfunction market size is expected to reach $4.25 billion by 2023.

Increasing disease awareness, growing patient willingness to seek medical assistance for disease management, and the increasing presence of favorable guidelines are driving the growth of the erectile dysfunction market. The three most popular erectile dysfunction drugs that are available are ED oral drugs, Viagra, Cialis, and Levitra. The global market is also witnessing a rising demand for low-cost generic drugs, especially in the APAC countries such as Indian and China.

The global erectile dysfunction market is driven by the wide availability of treatment options oral therapies and newly emergent low-intensity extra-corporeal shockwave therapy. The introduction of other conventional therapies such as oral, topical, penile injectables, and vacuum constriction devices will also create opportunities for vendors in the global erectile dysfunction market. The market research report provides in-depth market analysis and segmental analysis of the global erectile dysfunction market by product, distribution channel, material, and geography.

The study considers the present scenario of the global erectile dysfunction market and its market dynamics for the period 2018−2023. The study covers a detailed overview of various market growth enablers, restraints, and trends. It covers both the demand and supply sides of the market. The study also profiles and analyzes the top six leading companies and 12 other prominent companies operating in the market.

Get your free sample now! https://www.arizton.com/market-reports/erectile-dysfunction-market

Erectile Dysfunction Market – Vendor Profiles

Major Vendors
• Bayer AG
• Eli Lilly and Company
• VIVUS Inc.
• Pfizer
• Boston Scientific Corp.
• Coloplast A/S

Prominent Players
• Apricus Biosciences Inc.
• Endo International plc
• Futura Medical
• Premedon
• Teva Pharmaceutical Industries Limited (Teva)
• Zephyr Surgical Implants (ZSI)
• Augusta Medical Systems LLC (Augusta Medical)
• Post-T-Vac Medical
• Bonro Medical
• Cristalia Produtos Quimicos Farmaceuticos Ltd.
• SK Chemicals

Erectile Dysfunction Market – Segmentation

Market Segmentation by Therapy Type
• ED Drugs
o Oral Therapies
o Topical Therapies
o Intrauretheral suppositories & Penile injection therapies
• ED Devices
o Vacuum erection devices
o Penile Implants
o Others
Market Segmentation by Geography
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Italy
o Spain
• APAC
o Japan
o India
o China
o Australia
• Latin America
o Brazil
o Mexico
• MEA

Get your free sample now! https://www.arizton.com/market-reports/erectile-dysfunction-market

Erectile Dysfunction Market – Table of Contents

1 Research Methodology
2 Research Objectives
3 Research Process

4 Report Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of Study
4.3.1 Market Segmentation by Therapy Type
4.3.2 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Currency Conversion rate
5.2 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview OF Penile Erection and Erectile Dysfunction
7.2 Signs and Symptoms
7.3 Classification
7.3.1 Psychogenic ED
7.3.2 Neurogenic ED
7.3.3 Vasculogenic ED
7.4 Etiology of ED
7.5 Epidemiology

8 Disease Diagnosis and Treatment Guidelines
8.1 Diagnosis
8.2 Initial Assessment of Medical and Sexual History
8.3 Physical Examination
8.4 Laboratory Tests
8.5 Specialized Diagnostic Tests
8.5.1 Nocturnal Penile Tumescence (NPT) and Rigidity Test
8.5.2 Intracavernous Injection Test
8.5.3 Duplex Ultrasound of Penis
8.5.4 Arteriography and Dynamic Infusion Cavernosometry
8.5.5 Psychiatric Assessment
8.6 Treatment
8.6.1 Initial Treatment Approach
8.6.2 Treatment Options for ED

9 Pipeline Landscape
9.1 Overview
9.2 Key Investigational Drugs/Devices
9.3 Dormant/Terminated/Withdrawn Drug Candidates
9.4 Product Profile: Pheonix
9.4.1 Overview
9.4.2 Product Profile
9.4.3 Future Outlook
9.5 Product Profile: MED2002 (Glyceryl Trinitrate (GTN))
9.5.1 Overview
9.5.2 Product Profile
9.5.3 Future Outlook

10 Marketed Products Landscape
10.1 Overview
10.2 Product Approval Timeline
10.3 Comparative Analysis of ED Pharmaceuticals
10.3.1 Comparative Analysis of PDE5 inhibitors
10.4 Comparative Analysis Of ED Devices

11 Unmet needs In Erectile Dysfunction Market

12 Market Dynamics
12.1 Market Growth Enablers
12.1.1 Increase in Incidence of ED and Other Related Chronic Diseases
12.1.2 Increase in Adoption of Advanced Alternative Modalities
12.1.3 Increase in Disease Awareness
12.1.4 YOY Impact of Market Enablers
12.2 Market Growth Restraints
12.2.1 Low Treatment Seeking Pool
12.2.2 Key Patent Expiries and Increased Low-cost Generics Medicines
12.2.3 Risk of Counterfeit Versions
12.2.4 YOY Impact of Market Restraints
12.3 Market Opportunities & Trends
12.3.1 Technological Advances in ED Treatment Modalities
12.3.2 Advances in ED Drug Formulations
12.3.3 Increase in Strategic Agreements and Consolidations
12.3.4 YOY Impact of Trends and Opportunities
13 Global Erectile Dysfunction Market
13.1 market Overview
13.2 Market Size & Forecast

14 Erectile Dysfunction Market- by Therapy Type
14.1 Segment Overview

15 Drug Therapy Market
15.1 Overview
15.2 Oral Therapies
15.2.1 Market Size & Forecast
15.3 Topical Therapies
15.3.1 Market Size & Forecast
15.4 Injectable and Intraurethral Suppositories
15.4.1 Market Size & Forecast

16 Device Therapy Market
16.1 Overview
16.2 Penile Implants
16.2.1 Market Size & Forecast
16.3 Vacuum Therapy Devices
16.3.1 Market Size & Forecast
16.4 Others Erectile Dysfunction Devices
16.4.1 Market Size & Forecast

17 Erectile Dysfunction Market - Geography
17.1 Market Overview

18 North America: Erectile Dysfunction Market
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Erectile Dysfunction Drugs Market
18.3.1 Market Size & Forecast
18.4 Erectile Dysfunction Devices Market
18.4.1 Market Size & Forecast
18.5 Key Countries
18.5.1 US: Market Size & Forecast
18.5.2 Canada: Market Size & Forecast

19 Europe: Erectile Dysfunction Market
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Erectile Dysfunction Drugs Market
19.3.1 Market Size & Forecast
19.4 Erectile Dysfunction Devices Market
19.4.1 Market Size & Forecast
19.5 Key Countries
19.5.1 Germany: Market Size & Forecast
19.5.2 UK: Market Size & Forecast
19.5.3 France: Market Size & Forecast
19.5.4 Italy: Market Size & Forecast
19.5.5 Spain: Market Size & Forecast

20 APAC: Erectile Dysfunction Market
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Erectile Dysfunction Drugs Market
20.3.1 Market Size & Forecast
20.4 Erectile Dysfunction Devices Market
20.4.1 Market Size & Forecast
20.5 Key Countries
20.5.1 Japan: Market Size & Forecast
20.5.2 China: Market Size & Forecast
20.5.3 India: Market Size & Forecast
20.5.4 Australia: Market Size & Forecast

21 Latin America: Erectile Dysfunction Market
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Erectile Dysfunction Drugs Market
21.3.1 Market Size & Forecast
21.4 Erectile Dysfunction Devices Market
21.4.1 Market Size & Forecast
21.5 Key Countries
21.5.1 Brazil: Market Size & Forecast
21.5.2 Mexico: Market Size & Forecast

22 MEA: Erectile Dysfunction Market
22.1 Market Overview
22.2 Market Size & Forecast
22.3 Erectile Dysfunction Drugs Market
22.3.1 Market Size & Forecast
22.4 Erectile Dysfunction Devices Market
22.4.1 Market Size & Forecast

Looking for more information? Click Here https://www.arizton.com/market-reports/erectile-dysfunction-market

About Arizton Advisory & Intelligence

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize fool proof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-235-2040/+1 302 469 0707

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Erectile Dysfunction Market Size to Reach Revenues of over $4 Billion by 2023 – Arizton here

News-ID: 2103096 • Views:

More Releases for Erectile

Erectile Dysfunction Drugs Market Beyond the Bedroom: The Impact of Erectile Dys …
Erectile Dysfunction Drugs Market to reach over USD XX billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Erectile Dysfunction Drugs Market Size, Share & Trends Analysis Report By Drug (Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra)), Mode of Administration (Injections, Oral, Topical), Distribution Channel (hospital pharmacies, online pharmacies, and retail pharmacies), Region, Market
Global Erectile Dysfunction Devices Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Erectile Dysfunction Devices Market is projected to grow at a CAGR of 9.6% from 2023 to 2028. The market is driven by the increasing prevalence of erectile dysfunction amongst young men, advancements in medical technology, growing awareness and acceptance, the aging population, and strategic collaborations. Browse 147 Market Data Tables and 115 Figures spread through 163 Pages
Erectile dysfunction drugs market to Surpass erectile dysfunction drugs market | …
Global Erectile Dysfunction Drugs Market size was valued at USD 2130 million in 2021 and is projected to reach USD 3250 million by 2028, growing at a CAGR of 5.4% from 2021 to 2028 according to a new report by Intellectual Market Insights Research. Get Sample Report:https://www.intellectualmarketinsights.com/download-sample/IMI-003946 Scope of Erectile Dysfunction Drugs Market Report: A recent market research report added to repository of Intellectual Market Insights Research is an in-depth analysis of Global
Global Erectile Dysfunction Devices Market Report
As per GME studies, on the Global Erectile Dysfunction Devices Market, it is analyzed that the market will grow at a CAGR of 6.5%. Erectile dysfunction incidence increases with growing age, about 5-10% of men under 40 years are the possible suspects for the dysfunctionality. This is projected to drive the ED device market in the coming years also. Raising the aforementioned disease prevalence and the growing percentage of tobacco
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, …
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025. Request for Sample of This Research Report @ https://bit.ly/2NXzatD Top Key Players:- Bayer AG Pfizer Eli Lilly & Co. Vivus, Inc. S.K. Chemicals Co. Ltd. Dong-A Pharmaceutical Co. Ltd Meda Pharmaceuticals Apricus Biosciences Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying According to a new study published by Polaris Market Research the global erectile dysfunction
Erectile Dysfunction Market Industry Forecast till 2024
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a